Matches in Wikidata for { <http://www.wikidata.org/entity/Q58001136> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q58001136 description "article" @default.
- Q58001136 description "im August 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58001136 description "wetenschappelijk artikel" @default.
- Q58001136 description "наукова стаття, опублікована в серпні 2011" @default.
- Q58001136 name "Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population" @default.
- Q58001136 name "Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population" @default.
- Q58001136 type Item @default.
- Q58001136 label "Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population" @default.
- Q58001136 label "Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population" @default.
- Q58001136 prefLabel "Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population" @default.
- Q58001136 prefLabel "Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population" @default.
- Q58001136 P1433 Q58001136-07DF3352-8806-48F7-B6A7-973F4D983183 @default.
- Q58001136 P1476 Q58001136-A4E1E155-85D0-4D01-9D06-0AB0B626E420 @default.
- Q58001136 P2093 Q58001136-0461AA19-50CB-4171-AD8B-22C35B19E053 @default.
- Q58001136 P2093 Q58001136-11975063-FA7E-4583-BE48-3A4581B5234B @default.
- Q58001136 P2093 Q58001136-1616087A-5D0E-4D0E-BC44-EBEB5CFA464D @default.
- Q58001136 P2093 Q58001136-8B87A6FD-359F-41DB-A896-05B5B5C8D627 @default.
- Q58001136 P2093 Q58001136-9415D1BD-9071-4AE1-A94D-D4F157D80817 @default.
- Q58001136 P2093 Q58001136-98740B33-976B-4291-8C11-2D682A2A0F96 @default.
- Q58001136 P2093 Q58001136-CD3167D1-F1F2-43C7-92BF-815F68D38669 @default.
- Q58001136 P2093 Q58001136-DDCFAB65-8368-49B7-BEA8-A685EC94C6E4 @default.
- Q58001136 P2860 Q58001136-12883478-6E62-4EED-B2C6-434ECDC7709B @default.
- Q58001136 P304 Q58001136-9B4C6CC6-F02C-40CD-8C40-2F8859DFECA2 @default.
- Q58001136 P31 Q58001136-584E6292-F89F-4581-8C91-301C2F57ED76 @default.
- Q58001136 P356 Q58001136-8BD9AF97-B6A3-427B-B4C6-D40624C11227 @default.
- Q58001136 P433 Q58001136-7A2DAE36-8F69-40D0-91AF-6264E7162B49 @default.
- Q58001136 P478 Q58001136-F85EE019-EA62-470B-98D1-858864BB49BA @default.
- Q58001136 P50 Q58001136-FFA33373-7AEE-4274-B7BD-08F9AFEAAB9C @default.
- Q58001136 P577 Q58001136-11A7C527-59FE-4BB8-8BE1-D95D522C36CD @default.
- Q58001136 P698 Q58001136-324ACA8D-44F2-4EB4-8AFF-4F57B25D6C9E @default.
- Q58001136 P921 Q58001136-48B7078A-DA23-4C4D-9CB1-F2D6B3966EB4 @default.
- Q58001136 P921 Q58001136-8709F961-4D01-40D4-B4F2-6888CBDF7277 @default.
- Q58001136 P921 Q58001136-B7B1EEDA-12D2-495D-B637-055DCB4E019B @default.
- Q58001136 P356 EJE-11-0129 @default.
- Q58001136 P698 21566072 @default.
- Q58001136 P1433 Q3060778 @default.
- Q58001136 P1476 "Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population" @default.
- Q58001136 P2093 "Amaya Viros" @default.
- Q58001136 P2093 "Angela Riddell" @default.
- Q58001136 P2093 "Christopher M Nutting" @default.
- Q58001136 P2093 "Jen Hickey" @default.
- Q58001136 P2093 "Katie L Newbold" @default.
- Q58001136 P2093 "Kevin J Harrington" @default.
- Q58001136 P2093 "Merina Ahmed" @default.
- Q58001136 P2093 "Yolanda Barbachano" @default.
- Q58001136 P2860 Q27860760 @default.
- Q58001136 P304 "315-322" @default.
- Q58001136 P31 Q13442814 @default.
- Q58001136 P356 "10.1530/EJE-11-0129" @default.
- Q58001136 P433 "2" @default.
- Q58001136 P478 "165" @default.
- Q58001136 P50 Q30118915 @default.
- Q58001136 P577 "2011-08-01T00:00:00Z" @default.
- Q58001136 P698 "21566072" @default.
- Q58001136 P921 Q162606 @default.
- Q58001136 P921 Q274160 @default.
- Q58001136 P921 Q826522 @default.